Gene-specific contributions to mumps virus neurovirulence and neuroattenuation

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 7059-7069

  Sauder, Christian J ^a   Zhang, Cheryl X ^a   Ngo, Laurie ^a   Werner, Kellie ^a   Lemon, Ken ^b   Duprex, W Paul ^b,c   Malik, Tahir ^a   Carbone, Kathryn ^d   Rubin, Steven A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; COMPLEMENTARY DNA; GUANINE; NUCLEOPROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASEPTIC MENINGITIS; CONTROLLED STUDY; MOLECULAR CLONING; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RAT; VIROGENESIS; VIRUS ATTENUATION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; ATTENTION; CENTRAL NERVOUS SYSTEM; CERCOPITHECUS AETHIOPS; GENES, VIRAL; MUMPS VIRUS; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VERO CELLS; VIRULENCE; VIRUS REPLICATION;

MUMPS VIRUS; RATTUS;

EID: 79960410638     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00245-11     Document Type: Article

References (48)

1. Afzal, M. A., et al. 1999. Evaluation of the neurovirulence test for mumps vaccines. Biologicals 27:43-49.
2. Ali, A., and D. P. Nayak. 2000. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276:289-303.
3. Andrejeva, J., et al. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFNbeta promoter. Proc. Natl. Acad. Sci. U. S. A. 101:17264-17269.
4. Balraj, V., and E. Miller. 1995. Complications of mumps vaccines. Rev. Med. Virol. 5:219-227.
5. Bang, H. O., and J. Bang. 1943. Involvement of the central nervous system in mumps. Acta Med. Scand. 113:487-505.
6. Biacchesi, S., B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2007. Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro. J. Virol. 81:6057-6067.
7. Buchholz, U. J., S. Finke, and K. K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
8. Buesa-Gomez, J., M. N. Teng, C. E. Oldstone, M. B. Oldstone, and J. C. de la Torre. 1996. Variants able to cause growth hormone deficiency syndrome are present within the disease-nil WE strain of lymphocytic choriomeningitis virus. J. Virol. 70:8988-8992.
9. Carbone, K. M., and S. Rubin. 2007. Mumps virus, p. 1527-1542. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Wolters Kluwer, Lippinocott Williams & Wilkins, Philadelphia, PA.
10. Clarke, D. K., M. S. Sidhu, J. E. Johnson, and S. A. Udem. 2000. Rescue of mumps virus from cDNA. J. Virol. 74:4831-4838.
11. Coronel, E. C., T. Takimoto, K. G. Murti, N. Varich, and A. Portner. 2001. Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J. Virol. 75:1117-1123.
12. Curran, J., and D. Kolakofsky. 1999. Replication of paramyxoviruses. Adv. Virus Res. 54:403-422.
13. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 96:13910-13913.
14. Holland, J., et al. 1982. Rapid evolution of RNA Genomes. Science 215: 1577-1585.
15. Horton, R. M. 1995. PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Mol. Biotechnol. 3:93-99.
16. Iwasaki, M., et al. 2009. The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J. Virol. 83:10374-10383.
17. Kolakofsky, D., L. Roux, D. Garcin, and R. W. H. Ruigrok. 2005. Paramyxovirus mRNA editing, the 'rule of six' and error catastrophe: a hypothesis. J. Gen. Virol. 86:1869-1877.
18. Kubota, T., N. Yokosawa, S. Yokota, and N. Fujii. 2001. C terminal CYSRICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem. Biophys. Res. Commun. 283:255-259.
19. Kubota, T., et al. 2005. Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J. Virol. 79:4451-4459.
20. Lamb, R. A., and G. D. Parks. 2007. Paramyxoviridae: the viruses and their replication, p. 1449-1496. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Wolters Kluwer, Lippincott Williams and Wilkins, Philadelphia, PA.
21. Lemon, K., B. K. Rima, S. McQuaid, I. V. Allen, and W. P. Duprex. 2007. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J. Virol. 81:8293-8302.
22. Li, M., et al. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J. Virol. 83:7261-7272.
23. Malik, T. H., et al. 2007. A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo. J. Neurovirol. 13:513-521.
24. Malik, T. H., et al. 2007. Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. J. Gen. Virol. 88:2533-2541.
25. Malik, T. H., C. Wolbert, L. Nerret, C. Sauder, and S. Rubin. 2009. Single amino acid changes in the mumps virus haemagglutinin-neuraminidase and polymerase proteins are associated with neuroattenuation. J. Gen. Virol. 90:1741-1747.
26. Matsumoto, T. 1982. Assembly of paramyxoviruses. Microbiol. Immunol. 26:285-320.
27. Murphy, S. K., and G. D. Parks. 1997. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology 232:145-157.
28. Paterson, R. G., and R. A. Lamb. 1990. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J. Virol. 64:4137-4145.
29. Plotkin, S. A., and S. A. Rubin. 2008. Mumps vaccine, p. 435-465. In S. A. Plotkin, W. A. Orenstein, and P. A. Offit (ed.), Vaccines, 5th ed. Saunders Elsevier, Philadelphia, PA.
30. Rubin, S. A., et al. 2005. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J. Infect. Dis. 191:1123-1128.
31. Rubin, S. A., et al. 2003. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J. Virol. 77:11616-11624.
32. Rubin, S. A., et al. 2000. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J. Virol. 74:5382-5384.
33. Rubin, S. A., et al. 1999. The mumps virus neurovirulence safety test in rhesus monkeys: a comparison of mumps virus strains. J. Infect. Dis. 180: 521-525.
34. Sanz-Ramos, M., S. F. Diaz-San, C. Escarmis, E. Domingo, and N. Sevilla. 2008. Hidden virulence determinants in a viral quasispecies in vivo. J. Virol. 82:10465-10476.
35. Sauder, C. J., et al. 2006. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350:48-57.
36. Sauder, C. J., et al. 2009. Presence of lysine at aa 335 of the hemagglutininneuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence. Vaccine 27:5822-5829.
37. Schmitt, A. P., and R. A. Lamb. 2004. Escaping from the cell: assembly and budding of negative-strand RNA viruses, p. 145-196. In Y. Kawaoka (ed.), Biology of negative strand RNA viruses: the power of reverse genetics, 1st ed., vol. 283. Springer-Verlag, Heidelberg, Germany.
38. Schmitt, P. T., G. Ray, and A. P. Schmitt. 2010. The C-terminal end of PIV5 NP protein is important for virus-like particle production and M-NP protein interaction. J. Virol. 84:12810-12823.
39. Shaw, M. L., W. B. Cardenas, D. Zamarin, P. Palese, and C. F. Basler. 2005. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus-and toll-like receptor 3-triggered signaling pathways. J. Virol. 79:6078-6088.
40. Shimizu, K., et al. 2007. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res. 123:154-160.
41. Sidhu, M. S., J. P. Menonna, S. D. Cook, P. C. Dowling, and S. A. Udem. 1993. Canine distemper virus L gene: sequence and comparison with related viruses. Virology 193:50-65.
42. Skiadopoulos, M. H., et al. 2003. The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations. J. Virol. 77:270-279.
43. Takeuchi, K., K. Tanabayashi, M. Hishiyama, and A. Yamada. 1996. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225:156-162.
44. Takimoto, T., and A. Portner. 2004. Molecular mechanism of paramyxovirus budding. Virus Res. 106:133-145.
45. Teng, M. N., M. B. Oldstone, and J. C. de la Torre. 1996. Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants. Virology 223:113-119.
46. Vignuzzi, M., J. K. Stone, J. J. Arnold, C. E. Cameron, and R. Andino. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348.
47. Wilson, R. L., et al. 2006. Function of small hydrophobic proteins of paramyxovirus. J. Virol. 80:1700-1709.
48. Yamada, K., N. Ito, M. Takayama-Ito, M. Sugiyama, and N. Minamoto. 2006. Multigenic relation to the attenuation of rabies virus. Microbiol. Immunol. 50:25-32.